{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:47:50Z","timestamp":1784630870945,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.bbr.2008.12.027","type":"journal-article","created":{"date-parts":[[2009,1,2]],"date-time":"2009-01-02T14:28:52Z","timestamp":1230906532000},"page":"481-485","source":"Crossref","is-referenced-by-count":29,"title":["Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania"],"prefix":"10.1016","volume":"198","author":[{"given":"John P.","family":"Redrobe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander N.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2008.12.027_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bbr.2004.08.015","article-title":"Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania","volume":"158","author":"Arban","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2008.12.027_bib2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/0269881103017002004","article-title":"Young GABA-ergic drugs: exit stage left, enter stage right","volume":"17","author":"Ashton","year":"2003","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.bbr.2008.12.027_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1586\/14737175.2.2.239","article-title":"Role of mood stabilizers in bipolar disorder","volume":"2","author":"Bhagwagar","year":"2002","journal-title":"Expert Rev Neurotherapeutics"},{"key":"10.1016\/j.bbr.2008.12.027_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.279.5349.403","article-title":"A potassium channel mutation in neonatal human epilepsy","volume":"279","author":"Biervert","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bbr.2008.12.027_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3458.2005.tb00033.x","article-title":"Retigabine: chemical synthesis to clinical application","volume":"11","author":"Blackburn-Munro","year":"2005","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.bbr.2008.12.027_bib6","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0028-3908(00)00051-4","article-title":"The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex","volume":"39","author":"Cunningham","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2008.12.027_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.tpj.6500400","article-title":"PP2A-Bgamma subunit and KCNQ2 K+ channels in bipolar disorder","volume":"7","author":"Borsotto","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.bbr.2008.12.027_bib8","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/156802606777323728","article-title":"Kv7 channels: function, pharmacology and channel modulators","volume":"6","author":"Dalby-Brown","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bbr.2008.12.027_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.yebeh.2007.09.023","article-title":"Effect of the new antiepileptic drug retigabine in a rodent model of mania","volume":"12","author":"Dencker","year":"2008","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.bbr.2008.12.027_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-2999(02)01287-6","article-title":"Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352","volume":"437","author":"Dupuis","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2008.12.027_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0327(00)00299-8","article-title":"The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues","volume":"68","author":"Freeman","year":"2002","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bbr.2008.12.027_bib12","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1176\/ajp.133.10.1177","article-title":"A dopaminergic mechanism in mania","volume":"133","author":"Gerner","year":"1976","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2008.12.027_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1517\/14656566.7.4.401","article-title":"Anticonvulsants in the treatment of bipolar mania","volume":"7","author":"Goodnick","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bbr.2008.12.027_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0269881103017002003","article-title":"Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology","volume":"17","author":"Goodwin","year":"2003","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.bbr.2008.12.027_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000026528","article-title":"Modulation of calcium and potassium currents by lamotrigine","volume":"38","author":"Grunze","year":"1998","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.bbr.2008.12.027_bib16","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1113\/jphysiol.2007.149450","article-title":"Kv7 channels: interaction with dopaminergic and serotonergic neurotransmission in the CNS","volume":"586","author":"Hansen","year":"2008","journal-title":"J Physiol"},{"key":"10.1016\/j.bbr.2008.12.027_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/35036198","article-title":"Neuronal KCNQ potassium channels: physiology and role in disease","volume":"1","author":"Jentsch","year":"2000","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bbr.2008.12.027_bib18","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.neubiorev.2007.03.003","article-title":"Animal models of bipolar disorder","volume":"31","author":"Kato","year":"2007","journal-title":"Neurosci Biobehav Rev"},{"issue":"Suppl. 3","key":"10.1016\/j.bbr.2008.12.027_bib19","first-page":"15","article-title":"The emerging roles of GABAergic and antiglutamatergic agents in bipolar disorders","volume":"64","author":"Ketter","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbr.2008.12.027_bib20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/jpet.105.083923","article-title":"Anxiolytic effects of maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels","volume":"314","author":"Korsgaard","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2008.12.027_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1124\/mol.58.2.253","article-title":"Modulation of KCNQ2\/3 potassium channels by the novel anticonvulsant retigabine","volume":"58","author":"Main","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bbr.2008.12.027_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1471-4159.2007.04562.x","article-title":"Involvement of KCNQ2 subunits in [3H]dopamine release triggered by depolarization and pre-synaptic muscarinic receptor activation from rat striatal synaptosomes","volume":"102","author":"Martire","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2008.12.027_bib23","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0091-3057(90)90377-T","article-title":"Inhibition by antimanic drugs of hyperactivity induced by methamphetamine\u2013chlordiazepoxide mixture in mice","volume":"35","author":"Okada","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2008.12.027_bib24","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1124\/mol.61.4.921","article-title":"Effects of the anticonvulsant retigabine on cultured cortical neurons: changes in electroresponsive properties and synaptic transmission","volume":"61","author":"Otto","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bbr.2008.12.027_bib25","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1523\/JNEUROSCI.23-18-07227.2003","article-title":"KCNQ\/M currents in sensory neurons: significance for pain therapy","volume":"23","author":"Passmore","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2008.12.027_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF01924701","article-title":"Effect of lithium and other drugs on the amphetamine chlordiazeposice hyperactivity in mice","volume":"31","author":"Poitou","year":"1975","journal-title":"Experientia"},{"key":"10.1016\/j.bbr.2008.12.027_bib27","series-title":"Diagnostic and statistical manual of mental disorders\u2014fourth edition (DMS-IV)","author":"Rush","year":"2000"},{"key":"10.1016\/j.bbr.2008.12.027_bib28","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/2111312a0","article-title":"Combined effects of chlordiazepoxide and dexamphetamine on activity of rats in an unfamiliar environment","volume":"211","author":"Rushton","year":"1966","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2008.12.027_bib29","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0028-3908(01)00029-6","article-title":"KCNQ4 channel activation by BMS-204352 and retigabine","volume":"40","author":"Schr\u00f8der","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2008.12.027_bib30","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/25367","article-title":"Moderate loss of function of cyclic-AMP-modulated KCNQ2\/KCNQ3 K+ channels causes epilepsy","volume":"396","author":"Schroeder","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2008.12.027_bib31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0165-0327(85)90020-5","article-title":"Dopamine in manic depressive illness. A pharmacological synthesis","volume":"8","author":"Siverstone","year":"1985","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bbr.2008.12.027_bib32","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1523\/JNEUROSCI.21-15-05535.2001","article-title":"Activation of expressed KCNQ potassium currents and native neuronal m-type potassium currents by the anticonvulsant drug retigabine","volume":"21","author":"Tatulian","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2008.12.027_bib33","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1126\/science.282.5395.1890","article-title":"KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel","volume":"282","author":"Wang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bbr.2008.12.027_bib34","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1124\/mol.107.043216","article-title":"N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2\/Q3 potassium channel activator","volume":"73","author":"Wickenden","year":"2008","journal-title":"Mol Pharmacol"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432808007304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432808007304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T23:21:54Z","timestamp":1558048914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432808007304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0166432808007304"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2008.12.027","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}